Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AtriCure, Inc. Director's Dealing 2012

May 11, 2012

31802_dirs_2012-05-10_3fba7f3f-b360-45ec-bba5-24582cdc046a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2012-05-08

Reporting Person: Drachman David J (Director, President, CEO and Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-05-08 Common Stock M 18575 $1.33 Acquired 423681 Direct
2012-05-08 Common Stock S 18575 $9.10 Disposed 405106 Direct
2012-05-09 Common Stock M 2900 $1.33 Acquired 408006 Direct
2012-05-09 Common Stock S 2900 $9.06 Disposed 405106 Direct
2012-05-10 Common Stock M 1586 $1.33 Acquired 406692 Direct
2012-05-10 Common Stock S 1586 $9.04 Disposed 405106 Direct
2012-05-10 Common Stock M 87160 $1.33 Acquired 492266 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-08 Incentive Stock Option (right to buy) $1.33 M 18575 Disposed 2012-10-14 Common Stock (18575) Direct
2012-05-09 Incentive Stock Option (right to buy) $1.33 M 2900 Disposed 2012-10-14 Common Stock (2900) Direct
2012-05-10 Incentive Stock Option (right to buy) $1.33 M 1586 Disposed 2012-10-14 Common Stock (1586) Direct
2012-05-10 Incentive Stock Option (right to buy) $1.33 M 87160 Disposed 2012-10-14 Common Stock (87160) Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $9.06 to $9.12 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: This transaction was executed in multiple trades at prices ranging from $9.01 to $9.05 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: These options were granted on October 14, 2002 and are exercisable cumulatively at a rate of 25% per annum beginning on October 14, 2003 (one year from grant date).